The Myelodysplasia Transplantation-Associated Outcomes (MDS-TAO) Study
NCT02390414 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 290
Last updated 2023-04-03
Summary
The purpose of this observational study is to compare overall survival in older adults with myelodysplastic syndromes (MDS) who receive reduced intensity conditioning hematopoietic stem cell transplant (RIC HSCT) versus those who do not receive HSCT.
Conditions
- Myelodysplastic Syndromes (MDS)
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Gregory A Abel, MD, MPH · Dana-Farber Cancer Institute
Eligibility
- Min Age
- 60 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-05-31
- Primary Completion
- 2020-09-30
- Completion
- 2020-09-30
Countries
- United States
Study Locations
More Related Trials
-
Prospective and Retrospective Cohort Study of New Prognostic Factors With Peripheral Blood and Bone Marrow Evaluation at the Time of Diagnosis and During Treatment or Thereafter in Acute Leukemia (Acute Leukemia HSCT Cohort)
NCT02344953 ·Status: UNKNOWN
-
Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignancies
NCT00079391 ·Status: COMPLETED ·Phase: PHASE2
-
Serial Analysis of Chimerism in Patients With Refractory Cytopenia (RC) Transplanted With Reduced Intensity Conditioning (RIC)
NCT00682799 ·Status: COMPLETED
-
DNA Methylation in Allogeneic Hematopoietic Stem Cell Transplantation.
NCT03871296 ·Status: UNKNOWN
-
Constitution of a Biological Cohort Following Bone Marrow Sampling From MDS or AML Patients and Age-matched Healthy Donors
NCT03233074 ·Status: TERMINATED
-
Study of Quality of Life in Older vs. Younger Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes
NCT03558386 ·Status: COMPLETED
-
Study of Metabolic Syndrome in Adolescent and Young Adult Survivors of Childhood Leukemia Who Have Undergone Stem Cell Transplant
NCT00920842 ·Status: COMPLETED
-
Observational Study of Iron Overload in Stem Cell Transplantation
NCT00954720 ·Status: COMPLETED
-
Musculoskeletal Outcomes After Bone Marrow Transplant
NCT00558948 ·Status: COMPLETED
-
Non Interventional Study on Iron Toxicity After First Allo-transplant in MDS/CMML
NCT06267898 ·Status: COMPLETED
-
Allogeneic Hematopoietic Stem Cell Transplantation Evaluation in High Risk Myelodysplasia: an Observational Non-interventional Study
NCT01095874 ·Status: COMPLETED
-
Improving Blood Stem Cell Collection and Transplant Procedures
NCT01517035 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Comparison of Lower-risk MDS Patients With and Without Improvements in Fatigue Following Blood Transfusion Therapy
NCT04103359 ·Status: TERMINATED ·Phase: NA
-
RIC Regimen for Elderly or High Comorbidity Burden Patients Receiving Haplo-HSCT
NCT03412409 ·Status: RECRUITING ·Phase: PHASE2
-
Multimodal Sexual Dysfunction Intervention In HCT
NCT03803696 ·Status: COMPLETED ·Phase: NA
-
Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
NCT04528355 ·Status: RECRUITING
-
Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure
NCT03500731 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Comparison of Quality of Life in Patients Undergoing More Intensive Versus Less Intensive Chemotherapy and Radiation Preceding a Bone Marrow Transplant
NCT00004994 ·Status: COMPLETED
-
Evaluation, Treatment, and Training for Patients With Blood Disorders
NCT00001397 ·Status: COMPLETED
-
Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation
NCT02598752 ·Status: COMPLETED
-
MSC and HSC Coinfusion in Mismatched Minitransplants
NCT01045382 ·Status: TERMINATED ·Phase: PHASE2
-
Comparison of Peripheral Blood Stem Cell Transplantation With Bone Marrow Transplantation for the Treatment of Serious Hematological Malignancies
NCT00275678 ·Status: COMPLETED ·Phase: PHASE3
-
Improving Diagnosis in Idiopathic Cytopenia Using Gene Sequencing
NCT03026751 ·Status: UNKNOWN
-
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
NCT03128996 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Late Effects and HRQoL in Survivors of Allo-HSCT - a Cross Sectional Study
NCT06277479 ·Status: COMPLETED